Načítá se...
The Programmed Death-1 Immune Suppressive Pathway: Barrier to Anti-Tumor Immunity()
Programmed Death Ligand 1 (PD-L1, also known as B7 homolog 1 (B7-H1) or CD274) is a major obstacle to anti-tumor immunity because it (i) tolerizes/anergizes tumor-reactive T cells by binding to its receptor PD-1 (CD279); (ii) renders tumor cells resistant to CD8(+) T cell and FasL-mediated lysis; an...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185425/ https://ncbi.nlm.nih.gov/pubmed/25281753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1401572 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|